کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
236086 465658 2014 12 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
A control strategy for bioavailability enhancement by size reduction: Effect of micronization conditions on the bulk, surface and blending characteristics of an active pharmaceutical ingredient
ترجمه فارسی عنوان
یک استراتژی کنترل برای افزایش قابلیت زیستی با کاهش اندازه: اثر شرایط میکروکنترل شدن بر خصوصیات فله، سطح و ترکیب از یک ماده دارویی فعال
موضوعات مرتبط
مهندسی و علوم پایه مهندسی شیمی مهندسی شیمی (عمومی)
چکیده انگلیسی


• The effect of varying micronization conditions on an API is investigated.
• Varying micronization extents cause differences in bulk and surface properties.
• Blending kinetics, monitored by PAT, is affected by micronization extent.
• Excessive micronization can negatively impact bulk handling and processing efficiency.
• Study can guide API size selection for optimal processability and bioavailability.

In a Quality by Design (QbD) development environment the effect of early process parameters on downstream manufacturing parameters, and the ultimate effect on drug product quality, need to be understood. For poorly soluble drugs, size reduction is frequently employed to obtain consistent in-vivo exposures. As a result, micronization is a key early stage processing step for many active pharmaceutical ingredients (APIs).This paper demonstrates the effect of varying micronization conditions on an API for which micronization is deemed necessary to ensure consistent drug delivery after human administration. Material micronized to different extents are confirmed as different by surface area, surface energy, particle size analysis, bulk density and surface adhesion measurements.These material characteristics can be correlated with the outcomes from a key processing step, blending. The evolution of the blending process is followed using PAT techniques, so that an overall understanding of the relationship between particle properties and blend uniformity can be demonstrated.Execution of such a study during drug development can enable selection of the appropriate control strategy to ensure production of API in the desired range where consistent optimal bioavailability and downstream processability are achieved.

Fig. 1: Effect of micronization extent on the blending kinetics of API in drug product formulation blend, monitored by Near Infra Red (NIR)Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Powder Technology - Volume 258, May 2014, Pages 222–233
نویسندگان
, , , , , , , , ,